surmount 1 tirzepatide

surmount 1 tirzepatide SURMOUNT-1 Trial Summary: What Actually Showed Tirzepatide SURMOUNT-1 three year efficacy

Name: surmount 1 tirzepatide SURMOUNT-1 Trial Summary: What Actually Showed Tirzepatide SURMOUNT-1 three year efficacy
Brand: actil.am
SKU: 8698436431
Price: 27.72 USD
Availability: InStock
Rating: 4.3231 (18 reviews)

SKU: 8698436431

4.3

USD27.72 USD63.72

Pay in 4 interest-free payments of $6.93 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 22 - Aug 27

Description

Tirzepatide is a once-weekly injectable medicine used to help people with type 2 diabetes control blood sugar and, more recently, to support weight management

Circulation 149 , 450462 (2024)

Tirzepatide remains stable at temperatures up to 30 degrees Celsius (86 degrees Fahrenheit) for up to 21 days

To rule out inferiority, the FDA required CVOTs to show an upper boundary risk ratio of 1.3 (post approval), utilizing a two-sided 95% confidence interval (CI), for major adverse cardiovascular events (MACE) [55]